Joyzyme Group Limited (HKG:8622)
Hong Kong
· Delayed Price · Currency is HKD 0.350
+0.005 (1.45%)
At close: Mar 10, 2026
Joyzyme Group Revenue
Joyzyme Group had revenue of 12.33M CNY in the half year ending June 30, 2025, with 7.54% growth. This brings the company's revenue in the last twelve months to 25.77M, up 2.74% year-over-year. In the year 2024, Joyzyme Group had annual revenue of 25.36M with 2.96% growth.
Revenue (ttm)
25.77M CNY
Revenue Growth
+2.74%
P/S Ratio
6.39
Revenue / Employee
262.96K CNY
Employees
98
Market Cap
180.42M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.36M | 730.00K | 2.96% |
| Dec 31, 2023 | 24.63M | -701.00K | -2.77% |
| Dec 31, 2022 | 25.33M | -797.00K | -3.05% |
| Dec 31, 2021 | 26.13M | 4.16M | 18.94% |
| Dec 31, 2020 | 21.97M | -3.50M | -13.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PuraPharm Corporation | 346.76M |
| Extrawell Pharmaceutical Holdings | 52.65M |
| Kontafarma China Holdings | 891.73M |
| Tianda Pharmaceuticals | 310.50M |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.09B |
| Regent Pacific Group | 6.54M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| China NT Pharma Group Company | 20.45M |